Lamivudine (generic), Epivir, Epivir-HBV

Bookmark

Add to MyYahoo RSS

Lamivudine (generic), Epivir, Epivir-HBV News

News on Lamivudine (generic), Epivir, Epivir-HBV continually updated from thousands of sources around the net.

Friday Apr 4 | HIV and Hepatitis

Updated Perinatal Antiretroviral Therapy Guidelines for Pregnant Women with HIV

The U.S. Department of Health and Human Services has updated its guidelines for use of antiretroviral drugs by pregnant women with HIV, intended both to improve the health of women and to prevent transmission of the virus to their infants during gestation or delivery.

Comment?

Related Topix: HIV/AIDS, Health, Medicine, Retrovir, Zidovudine (generic), Norvir, Ritonavir (generic)

Thu Apr 03, 2014

BioMed Central

The impact of HBV or HCV infection in a cohort of HIV-infected...

Coinfection with the hepatitis viruses is common in the HIV population in sub-Saharan Africa.

Comment?

Related Topix: Hepatitis, Medicine, Health

Tue Mar 18, 2014

HIV and Hepatitis

CROI 2014: Lopinavir or Lamivudine Equally Protective Against HIV During Breast-feeding

Peri-exposure prophylaxis using either lopinavir/ritonavir and lamivudine proved equally protective as infant prophylaxis against HIV infection during 12 months of breast-feeding, according to a report at the 21st Conference on Retroviruses and Opportunistic Infections this month in Boston.

Comment?

Related Topix: HIV/AIDS, Health, Medicine, Kaletra, Lopinavir/Ritonavir (generic), Norvir, Ritonavir (generic), Viramune, Nevirapine (generic), World News, Zambia

Wed Mar 12, 2014

PR-inside.com

Global Epzicom market: Latest market analysis presented

ViiVs Epzicom is a fixed-dose combination of two NRTIs, Ziagen and Epivir . The drug is indicated in combination with other antiretrovirals for the treatment of HIV infection for adults, and for adults and adolescents over the age of 12 years, in the US and EU, respectively .

Comment?

Related Topix: Medicine, Ziagen, Abacavir (generic), HIV/AIDS, Health

Mon Mar 10, 2014

Aidsmap

Lopinavir/ritonavir or 3TC PrEP equally protective against infant HIV infection during breastfeeding

Lopinavir/ritonavir or 3TC proved equally protective as infant prophylaxis against HIV infection during 12 months of breastfeeding, Dr Chipepo Kankasa, presenting on behalf of the ANRS 12174 trial, told participants at the 21st Conference on Retroviruses and Opportunistic Infections last week in Boston.

Comment?

Related Topix: HIV/AIDS, Health, Norvir, Ritonavir (generic), Medicine, Kaletra, Lopinavir/Ritonavir (generic), Viramune, Nevirapine (generic)

•••
•••
•••
•••
•••
•••
•••
•••